Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
492
datasets available to search
ShareScore release 0.9.0
Dataset results
492 results for “EGFR mutations;”
Neoadjuvant Lazertinib With or Without Chemotherapy for Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT06268210. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical S
ClinicalTrials.gov study NCT07182682. IPD Sharing: NO. Countries: 1. Publications: 0.
S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC
ClinicalTrials.gov study NCT03457337. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation
ClinicalTrials.gov study NCT01516983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
ClinicalTrials.gov study NCT04590664. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Concomitant Mutation NSCLC
ClinicalTrials.gov study NCT04797806. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC
ClinicalTrials.gov study NCT05223595. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation
ClinicalTrials.gov study NCT02820116. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation
ClinicalTrials.gov study NCT06956001. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation
ClinicalTrials.gov study NCT06050980. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT06992739. IPD Sharing: NO. Countries: 0. Publications: 0.
Phase III Trial of SYS6010 Versus Platinum-based Chemotherapy for EGFR-mutated NSCLC（SYNSTAR01）
ClinicalTrials.gov study NCT06927986. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Almonertinib as Upfront Treatment for Uncommon EGFR Mutation Harboring Non-Small-Cell Lung Cancer Patients: A Multicenter, Open-Label, Phase II Trial
ClinicalTrials.gov study NCT04553887. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Me
ClinicalTrials.gov study NCT06667076. IPD Sharing: YES. Countries: 12. Publications: 0.
Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma
ClinicalTrials.gov study NCT06730477. IPD Sharing: NO. Countries: 1. Publications: 0.
Next Generation Sequencing Method for the Detection of EGFR Gene Mutations in the Plasma of Patients With Lung Cancer
ClinicalTrials.gov study NCT06595498. IPD Sharing: NO. Countries: 1. Publications: 0.
DZD6008 Combination Therapy in Patients With Locally Advanced or Metastatic NSCLC With EGFR Mutation (TIAN-SHAN7)
ClinicalTrials.gov study NCT07070440. IPD Sharing: NO. Countries: 1. Publications: 0.
A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations
ClinicalTrials.gov study NCT01131429. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01312337. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Explorative Study of Afatinib in the Treatment of Advanced Cancer Carrying an EGFR, a HER2 or a HER3 Mutation
ClinicalTrials.gov study NCT03810872. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.